The abnormal proliferation capacity of tumor cells is related to the enhancement of cell viability, indicating that low levels of MMP23B (Matrix Metalloproteinase 23B) reduce the proliferation capacity of endometrial cancer cells. This evidence concerns the gene MMP23B and endometrial cancer.